Bills in the 2022 Regular Session, House.
Rachel Prusak
Sponsored
Out of committee2
Requires pharmacist who dispenses opioid prescription to offer prescription for naloxone, or similar drug, and information about naloxone under specified circumstances.
Requires individual and group health insurance policies, health care service contractors and multiple employer welfare arrangements to provide reimbursement for at least three primary care visits annually in addition to one annual preventive primary care visit covered without cost-sharing.
Carried from the Senate
Became law1
Includes specified documentation, when authorized by victim, in definition of "sexual assault forensic evidence kit" for purposes of statutes regulating collection, testing and retention of kits.
Co-sponsored
Became law · 8
Requires Oregon Health Authority, guided by advisory committee to be convened by authority, to provide grants to operate two culturally and linguistically specific mobile health units, as pilot program, to improve health outcomes of Oregonians impacted by racism.
Modifies composition and duties of Oregon Broadband Advisory Council.
Authorizes health care practitioner authorized in another state or United States territory to practice in this state without compensation for specified number of days without obtaining licensure in this state.
Adds to cancers covered by rebuttable presumption of occupational disease for eligible nonvolunteer firefighters.
Directs Legislative Policy and Research Office to prepare report concerning Oregon's current framework for preventing, monitoring and responding to zoonotic disease.
Requires insurer and health care service contractor to cover labor and delivery services provided at out-of-network health care facility, and medical transport of individual presenting with signs of labor from in-network facility to out-of-network facility, if services provided at out-of-network facility due solely to diversion of patient from in-network health care facility for reasons related to state or federal declaration of public health emergency.
Requires Health Information Technology Oversight Council to convene one or more groups of stakeholders and experts to explore options to accelerate, support and improve secure, statewide community information exchanges.
Directs Oregon Film and Video Office to establish Creative Opportunity Program to promote film, television, interactive, animation and media industries in Oregon.
Passed the House · 1
Expands crime of assault in the third degree to include causing physical injury to person working in hospital while worker is performing official duties.
Out of committee · 4
Requires individual and group health insurance policies to reimburse services provided by naturopathic physicians within scope of their practice if services are reimbursed when provided by licensed physicians.
Directs Newborn Bloodspot Screening Advisory Board to evaluate and make recommendations on adding diseases to Oregon newborn bloodspot screening panel under specific circumstances.
Directs University of Oregon to conduct study on prevalence of child abuse in this state and to submit report regarding study to interim committees of Legislative Assembly related to human services.
Directs Governor to designate corrections gender-responsive coordinator.
In committee · 5
Requires Director of Oregon Department of Administrative Services to study development and administration of program to make payments to essential workers for services performed during COVID-19 pandemic and report findings to interim committees of Legislative Assembly related to labor on or before September 15, 2023.
Allows private entity to swipe driver license or identification card to submit information to electronic system for purpose of transferring drug containing pseudoephedrine.
Allows pharmacy intern to transfer drug containing pseudoephedrine subject to requirements that apply to transfer by pharmacist and pharmacy technician.
Imposes requirements for accepting bids and proposals for contracts for provision and delivery of publicly financed behavioral health or addiction treatment or services.
Prohibits manufacturer or supplier from manufacturing, selling, offering to sell or distributing cosmetic or ingredient developed through use of animal test.